Jazz Pharmaceuticals Earning Date (JAZZ)

USA |NASDAQ |USD

JAZZ Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 (est) Jun 30, 2022 - - $3.90
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 (est) Jun 30, 2022 - - $751.81M

Jazz Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

JAZZ Earnings Date & History Chart

JAZZ Earnings & Revenue Forecast

JAZZ Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 16 $4.40 $4.05 $4.87
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 18 $16.53 $15.92 $17.58
Dec 2023 17 $17.44 $12.87 $22.16

JAZZ Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 4 / 0 $4.27 $4.08 $3.97
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 1 $16.51 $17.49 $17.46
Dec 2023 1 / 1 $17.79 $18.84 $18.64

JAZZ Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 14 $911.64M $857.64M $952.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 18 $3.59B $3.50B $3.67B
Dec 2023 18 $3.80B $3.43B $4.30B

JAZZ Earnings Date & Revenue History

JAZZ Earnings History

|
Show More
Show More

JAZZ Revenue History

|
Show More
Show More

Jazz Pharmaceuticals Next Earnings Date & Report

JAZZ May 2022 (FQ) Earnings Date & Report Preview

JAZZ's next estimated earnings date (based on same quarter last year's report date) is Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Jazz Pharmaceuticals Previous Earnings Dates & Reports

JAZZ Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Jazz Pharmaceuticals's previous earnings date was May 2, 2022 for its fiscal quarter ended Mar 31, 2022.

JAZZ Previous Earnings Date & Report Recap: Dec 2021 (FY)

Jazz Pharmaceuticals's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.

JAZZ's earnings per share (EPS) was $16.23, beating the consensus analysts forecast of $15.68 by 3.51% , and higher than the previous year's EPS (Dec 2020) by 30.15%.

Revenues were $3.09B, worse than the forecast of $3.09B by -0.00%, and up by 30.91% from previous year's revenue.

The company reported a net income of $-329.67M.

Jazz Pharmaceuticals reported a free cash flow of $732.98M for its fiscal year, compared to $520.39M a year ago.

The company ended the fiscal year with $6.15B in total debt, an increase of 191.70% compared to the previous year.